CLEC16A
Basic information
Region (hg38): 16:10944539-11182186
Previous symbols: [ "KIAA0350" ]
Links
Phenotypes
GenCC
Source:
- schizophrenia (No Known Disease Relationship), mode of inheritance: Unknown
ClinVar
This is a list of variants' phenotypes submitted to
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the CLEC16A gene is commonly pathogenic or not.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
Variant type | Pathogenic | Likely pathogenic | VUS | Likely benign | Benign | Sum |
---|---|---|---|---|---|---|
synonymous | 5 | |||||
missense | 72 | 79 | ||||
nonsense | 0 | |||||
start loss | 0 | |||||
frameshift | 0 | |||||
inframe indel | 0 | |||||
splice donor/acceptor (+/-2bp) | 0 | |||||
splice region | 0 | |||||
non coding | 0 | |||||
Total | 0 | 0 | 72 | 11 | 1 |
Variants in CLEC16A
This is a list of pathogenic ClinVar variants found in the CLEC16A region.
You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.
Position | Type | Phenotype | Significance | ClinVar |
---|---|---|---|---|
16-10944763-A-G | not specified | Uncertain significance (Nov 18, 2022) | ||
16-10957794-C-T | not specified | Likely benign (Jun 16, 2024) | ||
16-10957816-G-A | not specified | Uncertain significance (May 26, 2024) | ||
16-10957834-A-C | not specified | Uncertain significance (Dec 19, 2023) | ||
16-10962469-A-G | not specified | Uncertain significance (Feb 27, 2023) | ||
16-10962501-C-G | not specified | Uncertain significance (May 14, 2024) | ||
16-10962528-G-A | not specified | Uncertain significance (Apr 09, 2024) | ||
16-10972945-C-A | not specified | Uncertain significance (Dec 08, 2023) | ||
16-10972946-C-G | not specified | Uncertain significance (Jan 17, 2024) | ||
16-10972947-A-C | not specified | Uncertain significance (Oct 12, 2021) | ||
16-10977225-G-A | not specified | Likely benign (Apr 22, 2024) | ||
16-10977253-C-G | not specified | Uncertain significance (Dec 02, 2022) | ||
16-10977290-A-G | not specified | Uncertain significance (Dec 17, 2023) | ||
16-10977307-A-C | not specified | Uncertain significance (Dec 28, 2022) | ||
16-10977331-C-T | not specified | Uncertain significance (Sep 26, 2023) | ||
16-10979333-G-A | not specified | Uncertain significance (May 23, 2023) | ||
16-10979338-C-T | Meniere disease | Uncertain significance (Jun 03, 2024) | ||
16-10982881-T-G | not specified | Uncertain significance (Oct 12, 2021) | ||
16-10982902-C-A | Uncertain significance (Oct 01, 2022) | |||
16-10982971-C-G | not specified | Uncertain significance (May 14, 2024) | ||
16-11003075-C-T | not specified | Uncertain significance (Mar 12, 2024) | ||
16-11003090-G-A | not specified | Uncertain significance (Aug 10, 2023) | ||
16-11003114-C-T | not specified | Uncertain significance (Jul 19, 2022) | ||
16-11003123-G-A | not specified | Uncertain significance (Jan 11, 2023) | ||
16-11003159-G-A | not specified | Uncertain significance (Apr 24, 2023) |
GnomAD
Source:
Gene | Type | Bio Type | Transcript | Coding Exons | Length |
---|---|---|---|---|---|
CLEC16A | protein_coding | protein_coding | ENST00000409790 | 24 | 237702 |
pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
---|---|---|---|---|---|---|
0.276 | 0.724 | 124949 | 0 | 24 | 124973 | 0.0000960 |
Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
---|---|---|---|---|---|---|
Missense | 1.21 | 549 | 635 | 0.864 | 0.0000396 | 6887 |
Missense in Polyphen | 129 | 188.8 | 0.68325 | 2077 | ||
Synonymous | -2.16 | 322 | 276 | 1.16 | 0.0000197 | 2035 |
Loss of Function | 4.91 | 11 | 47.5 | 0.232 | 0.00000236 | 579 |
LoF frequencies by population
Ethnicity | Sum of pLOFs | p |
---|---|---|
African & African-American | 0.000217 | 0.000213 |
Ashkenazi Jewish | 0.00 | 0.00 |
East Asian | 0.000170 | 0.000167 |
Finnish | 0.000146 | 0.000139 |
European (Non-Finnish) | 0.000109 | 0.000106 |
Middle Eastern | 0.000170 | 0.000167 |
South Asian | 0.0000330 | 0.0000327 |
Other | 0.00 | 0.00 |
dbNSFP
Source:
- Function
- FUNCTION: Regulator of mitophagy through the upstream regulation of the RNF41/NRDP1-PRKN pathway. Mitophagy is a selective form of autophagy necessary for mitochondrial quality control. The RNF41/NRDP1-PRKN pathway regulates autophagosome-lysosome fusion during late mitophagy. May protect RNF41/NRDP1 from proteosomal degradation, RNF41/NRDP1 which regulates proteosomal degradation of PRKN. Plays a key role in beta cells functions by regulating mitophagy/autophagy and mitochondrial health. {ECO:0000269|PubMed:24949970}.;
- Pathway
- Vitamin D Receptor Pathway
(Consensus)
Recessive Scores
- pRec
- 0.178
Intolerance Scores
- loftool
- 0.775
- rvis_EVS
- -1.01
- rvis_percentile_EVS
- 8.2
Haploinsufficiency Scores
- pHI
- 0.335
- hipred
- Y
- hipred_score
- 0.605
- ghis
- 0.578
Essentials
- essential_gene_CRISPR
- N
- essential_gene_CRISPR2
- N
- essential_gene_gene_trap
- N
- gene_indispensability_pred
- E
- gene_indispensability_score
- 0.547
Gene Damage Prediction
All | Recessive | Dominant | |
---|---|---|---|
Mendelian | Medium | Medium | Medium |
Primary Immunodeficiency | Medium | Medium | Medium |
Cancer | Medium | Medium | Medium |
Mouse Genome Informatics
- Gene name
- Clec16a
- Phenotype
- homeostasis/metabolism phenotype; cellular phenotype; growth/size/body region phenotype; endocrine/exocrine gland phenotype; hearing/vestibular/ear phenotype; limbs/digits/tail phenotype; vision/eye phenotype; mortality/aging (the observable characteristics related to the ability of a mammalian organism to live and age that are manifested throughout development and life span);
Gene ontology
- Biological process
- autophagy;endosome to lysosome transport;cellular response to starvation;endosomal transport;negative regulation of proteasomal ubiquitin-dependent protein catabolic process;negative regulation of autophagosome maturation;positive regulation of autophagosome maturation;negative regulation of mitophagy;positive regulation of TORC1 signaling;negative regulation of macroautophagy by TORC1 signaling
- Cellular component
- late endosome;Golgi apparatus;cytosol;integral component of membrane;vesicle;endolysosome membrane
- Molecular function
- molecular_function;Rab GTPase binding